Syvälahti E K, Kanto J H
Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):74-82.
The effect of diazepam on blood glucose, serum immunoreactive insulin (IRI), and growth hormone (GH) were studied in 10 volunteers who received diazepam in oral doses of 5 and 10 mg, and intravenously 10 mg. They also received placebo and saline treatment. There was a dose-dependent rise in GH after diazepam administration, and the rise was related to the peak plasma level of the drug. A highly significant correlation between the concentrations of serum GH and plasma diazepam was found. During the i.v. and oral administration of 10 mg of diazepam, the peak GH levels, reached in 30 and 60 minutes (19.6+/-2.9 and 15.2+/-3.2ng/ml, respectively), were significantly higher than those during saline and placebo periods (4.3+/-0.8 and 5.9+/-1.1 ng/ml, respectively). There was a tendency to a rise of blood glucose levels, but no significant changes of serum IRI.
对10名志愿者进行了研究,观察地西泮对血糖、血清免疫反应性胰岛素(IRI)和生长激素(GH)的影响。这些志愿者口服5毫克和10毫克地西泮,并静脉注射10毫克地西泮。他们还接受了安慰剂和生理盐水治疗。服用地西泮后,GH呈剂量依赖性升高,且这种升高与药物的血浆峰值水平相关。发现血清GH浓度与血浆地西泮浓度之间存在高度显著的相关性。在静脉注射和口服10毫克地西泮期间,分别在30分钟和60分钟达到的GH峰值水平(分别为19.6±2.9和15.2±3.2纳克/毫升)显著高于生理盐水和安慰剂治疗期间的水平(分别为4.3±0.8和5.9±1.1纳克/毫升)。血糖水平有升高的趋势,但血清IRI没有显著变化。